RadioMedix.jpg
Viewpoint MT and RadioMedix secured a second SBIR NCI grant for image guided therapy of metastatic melanoma
27 août 2015 00h00 HE | RadioMedix Inc.
Houston, TX, Aug. 27, 2015 (GLOBE NEWSWIRE) -- Viewpoint Molecular Targeting LLC.(Iowa City, IO) and RadioMedix Inc. (Houston TX) partnership resulted in the second Small Business Innovation...